Cantor Fitzgerald Keeps a Buy Rating on UnitedHealth


Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on UnitedHealth (NYSE: UNH) today and set a price target of $300. The company’s shares closed on Tuesday at $246.98, close to its 52-week high of $256.73.

Halper wrote:

“. We reiterate our Overweight rating on UNH shares and our price target remains at $300 (representing about 21% upside from current levels). The company kicks off 2Q18 reporting season on Tuesday, July 17. Overall, we expect the company to report strong results, continuing the trend from 1Q18. 1Q18 results were driven by strong growth in Medicare and Medicaid. We assume just marginal growth in commercial membership from 1Q18 levels. Indeed, Optum remains an important growth driver for the company, both as a standalone business unit as well as enabling the performance of the company’s captive (UHC) health plans.”

According to TipRanks.com, Halper is a top 100 analyst with an average return of 20.6% and a 73.5% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for UnitedHealth with a $280.57 average price target, a 13.6% upside from current levels. In a report issued on June 21, BMO Capital also maintained a Buy rating on the stock with a $300 price target.

.

See today’s analyst top recommended stocks >>

The company has a one-year high of $256.73 and a one-year low of $183.86. Currently, UnitedHealth has an average volume of 2.76M.

Based on the recent corporate insider activity of 178 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts